comparemela.com

Latest Breaking News On - Contact dawn chi corporate communications - Page 1 : comparemela.com

TLC to Present at the 42nd Annual JP Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec. 27, 2023 (GLOBE NEWSWIRE) TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the company will present at the 42nd Annual JP Morgan Healthcare Conference at 2:00pm PT on Tuesday, January 9, 2024. As a part of the APAC track, TLC will present at the Golden Gate Ballroom at the Marriott Marquis, 780 Mis

TLC Announces TLC599 Agreement with Endo

TLC Announces TLC599 Agreement with Endo
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

InspirMed to Present at the 23rd International Society for Aerosols in Medicine (ISAM) Congress

Press release content from Globe Newswire. The AP news staff was not involved in its creation. InspirMed to Present at the 23rd International Society for Aerosols in Medicine (ISAM) Congress TLCApril 26, 2021 GMT SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, April 26, 2021 (GLOBE NEWSWIRE) InspirMed Inc., a subsidiary of TLC (Nasdaq: TLC, TWO: 4152) that specializes in the development of inhalable liposome formulation programs, announced today that a late-breaking abstract describing the potential advantages of ISPM21 and ISPM19 has been accepted by the scientific committee for poster presentation at the 23rd International Society for Aerosols in Medicine (ISAM) Congress. The poster, titled “A Strategy to Treat COVID-19 with Targeted Delivery of Inhalable Liposomal Antiviral Drugs”, has a poster number of 072 (New Devices and Emerging Therapies) and will be posted both on the website ( www.isam.org ) with an opportunity for a short oral presentation and printed for displ

TLC to Present at Upcoming Virtual Investor Conferences

Press release content from Globe Newswire. The AP news staff was not involved in its creation. TLC to Present at Upcoming Virtual Investor Conferences TLCMarch 2, 2021 GMT SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 02, 2021 (GLOBE NEWSWIRE) TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that the Company’s management team will be presenting at the following virtual investor conferences: HC Wainwright & Co Global Life Sciences Conference (March 9-10, 2021) Presentation: on-demand starting 7am ET, Tuesday, March 9, 2021 ADVERTISEMENT Presentation: 8am ET, Wednesday, March 17, 2021 The management team will also be participating in one-on-one meetings during the conference. The corporate presentation will be available on the TLC website at www.tlcbio.com in the Investors section, under News & Events.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.